Lamivir HBV 100mg (Lamivudine)

Description

Lamivir HBV 100mg (Lamivudine 100mg) Tablets

Lamivir HBV 100mg contains lamivudine 100mg, an antiviral medicine used for chronic hepatitis B (HBV) in appropriate patients. Lamivudine belongs to the nucleoside analogue reverse transcriptase inhibitor class. It reduces hepatitis B virus replication and can help control chronic HBV infection.

Lamivir HBV 100mg Lamivudine: What Is It?

Lamivir HBV 100mg is a prescription tablet containing lamivudine 100mg. The product shown here is marketed by Cipla and is specifically labeled for hepatitis B.

Lamivudine is also known as 3TC. It belongs to the nucleoside analogue reverse transcriptase inhibitor class.

Unlike the higher-dose lamivudine formulations used for HIV treatment, the 100mg HBV formulation has a specific role in chronic hepatitis B therapy. Therefore, patients should use the exact formulation and dose prescribed by their healthcare professional.

Lamivir HBV 100mg Lamivudine Uses

Lamivir HBV 100mg is used to treat chronic hepatitis B virus infection when there is evidence of HBV replication and active liver inflammation.

Lamivudine works by interfering with HBV DNA synthesis. As a result, it can reduce viral replication and lower HBV levels in the blood.

However, lamivudine does not guarantee elimination of hepatitis B from the body. In addition, resistance can develop during treatment. Consequently, regular medical monitoring remains important.

What Is Lamivudine Used For?

Lamivudine is an antiviral medicine used in different formulations and strengths. The 100mg HBV formulation is specifically used for chronic hepatitis B.

Lamivudine is also used in higher-dose formulations as part of combination treatment for HIV-1 infection. These products should not be confused with Lamivir HBV 100mg.

Therefore, always check the product strength, formulation, and indication before using a lamivudine medicine.

How Does Lamivir HBV 100mg Lamivudine Work?

Lamivudine inhibits viral reverse transcriptase and DNA polymerase activity. Inside infected cells, its active form interferes with viral DNA synthesis.

Consequently, hepatitis B virus has less ability to produce new viral DNA. This action can reduce HBV replication.

Nevertheless, viral suppression does not necessarily mean that chronic hepatitis B has been cured. Patients should continue appropriate follow-up and testing.

Lamivir HBV 100mg Composition

• Active ingredient: Lamivudine
• Strength: 100mg
• Dosage form: Tablet
• Drug class: Nucleoside analogue reverse transcriptase inhibitor
• Other name: 3TC
• Brand: Lamivir HBV
• Manufacturer/marketer shown: Cipla
• Pack shown: 10 × 10 tablets

Lamivudine 100mg Dose for Hepatitis B

The current U.S. labeling for lamivudine tablets used for chronic hepatitis B recommends 100mg once daily for adults.

For pediatric patients aged 2 to 17 years, the labeled dose is 3mg per kg once daily, up to a maximum of 100mg once daily. The oral solution may be used when a dose below 100mg is required.

Patients with reduced kidney function require dosage adjustment. Therefore, healthcare professionals should assess renal function when selecting the dose.

For current prescribing details, review the DailyMed lamivudine HBV prescribing information.

How to Take Lamivir HBV 100mg

Take Lamivir HBV exactly as prescribed by your healthcare professional.

• Take 100mg once daily when prescribed for chronic hepatitis B.
• Take the medicine at approximately the same time each day.
• Follow the instructions provided with your prescription.
• Do not change the dose yourself.
• Do not stop treatment without medical advice.

Lamivudine can be taken with or without food. More importantly, take it consistently to maintain antiviral treatment.

Lamivir HBV 100mg Lamivudine Side Effects

Some people may experience side effects while taking lamivudine. In clinical studies of the HBV formulation, commonly reported reactions included ear, nose, and throat infections, sore throat, and diarrhea.

Possible side effects may include:

• Diarrhea
• Sore throat
• Headache
• Tiredness
• Digestive discomfort
• Upper respiratory symptoms

Side effects vary between individuals. Therefore, contact your healthcare professional if a reaction becomes severe, persistent, or concerning.

Serious Lamivudine 100mg Side Effects

Lamivudine has important safety warnings. Rare but serious problems can include lactic acidosis and severe hepatomegaly with steatosis.

Seek prompt medical attention if you develop:

• Severe weakness or unusual tiredness
• Persistent nausea or vomiting
• Severe abdominal discomfort
• Difficulty breathing
• Unusual muscle pain
• Yellowing of the skin or eyes
• Dark urine

Although these complications are uncommon, prompt evaluation can help identify serious problems early.

Lamivir HBV 100mg and Hepatitis B

Chronic hepatitis B can remain active for many years. Some people may have few or no symptoms even when the virus continues to affect the liver.

Lamivudine can suppress HBV replication. However, long-term treatment decisions depend on viral activity, liver health, resistance, and other clinical factors.

Regular laboratory monitoring helps healthcare professionals evaluate treatment response. For general information about hepatitis B, visit MedlinePlus Hepatitis B.

Lamivudine Resistance and Hepatitis B

One important limitation of lamivudine therapy is the development of resistance-associated HBV changes.

Current U.S. labeling notes that treatment should be evaluated regularly and that an alternative antiviral may need consideration when HBV DNA remains detectable after treatment.

Therefore, healthcare professionals may monitor HBV DNA and liver-related laboratory results during therapy.

Lamivir HBV 100mg and HIV

HIV testing is important before starting the HBV-specific lamivudine formulation.

The 100mg HBV dose is lower than the lamivudine dose used in HIV treatment. If a person has unrecognized HIV infection, using the HBV formulation alone can provide inadequate HIV activity and may contribute to HIV resistance.

Consequently, patients with possible or known HIV infection need an appropriate HIV treatment regimen rather than lamivudine HBV monotherapy.

The current DailyMed label specifically warns about the risk of HIV-1 resistance when HBV lamivudine is used in people with unrecognized or untreated HIV infection.

Lamivir HBV 100mg vs Lamivudine 150mg

The active ingredient is the same, but the formulations serve different treatment purposes. Therefore, these tablets should not be substituted based only on the name lamivudine.

Lamivudine 100mg vs Tenofovir

Lamivudine and tenofovir are both antiviral medicines used in hepatitis B treatment. However, they have different active ingredients and different resistance profiles.

Current U.S. labeling notes that lamivudine has a high rate of resistance development in treated HBV patients. Consequently, treatment selection should consider whether an alternative antiviral with a higher genetic barrier is available and appropriate.

Doctors may consider tenofovir-based therapy or other options depending on the patient’s clinical situation.

Lamivudine and Dolutegravir

Dolutegravir and lamivudine can be used together in certain HIV treatment regimens.

Dolutegravir is an integrase strand transfer inhibitor, while lamivudine is an NRTI. These medicines target HIV through different mechanisms.

However, the HIV formulations and doses differ from Lamivir HBV 100mg. Therefore, do not use the HBV formulation as a substitute for an HIV regimen.

Lamivudine and Zidovudine

Lamivudine and zidovudine are both NRTIs. They have been used together in certain HIV treatment combinations.

Modern HIV treatment has changed over time, and healthcare professionals now select regimens according to current guidelines, resistance history, interactions, tolerability, and individual needs.

Lamivudine and Abacavir

Abacavir and lamivudine are available together in certain HIV medicines. Some regimens also include dolutegravir.

However, these products are intended for HIV treatment rather than chronic HBV treatment. Therefore, patients should use the exact product prescribed for their condition.

Lamivudine and Emtricitabine

Lamivudine and emtricitabine are both NRTIs with similar antiviral activity.

The current HBV lamivudine label specifically states that lamivudine HBV tablets should not be used together with other medicines containing lamivudine or emtricitabine.

Consequently, do not combine these medicines unless a qualified healthcare professional specifically directs you to do so.

Lamivudine 3TC: What Does 3TC Mean?

3TC is another name for lamivudine. The term appears in HIV treatment literature and in the names of some combination medicines.

However, 3TC and lamivudine refer to the same active ingredient. The exact strength and formulation still matter when selecting a medicine.

Lamivudine Drug Class

Lamivudine belongs to the nucleoside analogue reverse transcriptase inhibitor class.

Other NRTIs include zidovudine, abacavir, and certain tenofovir formulations. Each medicine has different dosing requirements, indications, safety considerations, and resistance characteristics.

Lamivir HBV 100mg and Kidney Function

Kidney function affects lamivudine clearance from the body. Therefore, patients with reduced renal function may need a lower dose or modified dosing schedule.

Tell your healthcare professional if you have kidney disease or receive dialysis. Appropriate kidney assessment can help determine the correct dose.

Lamivir HBV 100mg and Liver Disease

Lamivir HBV is used for chronic hepatitis B, but the severity of liver disease affects treatment decisions.

The current U.S. label states that lamivudine HBV tablets have not been evaluated in patients with decompensated liver disease. Therefore, people with advanced liver disease should receive specialist medical evaluation.

Can Lamivudine 100mg Cure Hepatitis B?

No. Lamivudine does not guarantee a cure for chronic hepatitis B.

The medicine reduces HBV replication and can improve certain markers of viral activity. However, hepatitis B can remain in the body, and treatment may require ongoing monitoring.

What Happens If You Stop Lamivir HBV 100mg?

Do not stop Lamivir HBV without medical advice.

Severe acute exacerbations of hepatitis B have occurred after discontinuation of lamivudine therapy. Therefore, healthcare professionals should monitor liver function closely after treatment stops.

In some cases, restarting or changing anti-HBV treatment may become necessary.

What Happens If You Miss a Lamivudine 100mg Dose?

If you miss a dose, follow your healthcare professional’s instructions. Do not take a double dose unless specifically instructed.

Try to take the medicine at the same time each day. In addition, maintaining a consistent treatment schedule can help support viral suppression.

Lamivir HBV 100mg During Pregnancy

Tell your healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.

Pregnancy can affect hepatitis B treatment decisions. Therefore, people who are pregnant should discuss the treatment plan with an appropriate healthcare professional.

Do not stop antiviral treatment independently because of pregnancy. Instead, seek individualized medical advice.

Lamivir HBV 100mg and Breastfeeding

Discuss breastfeeding with your healthcare professional before starting or continuing lamivudine.

Your healthcare professional can assess the benefits and potential risks based on your hepatitis B status and individual circumstances.

Lamivudine 100mg Drug Interactions

Tell your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins, supplements, and herbal products you use.

One important interaction involves sorbitol. Chronic coadministration may lower lamivudine concentrations. Therefore, healthcare professionals may recommend avoiding long-term combined use when possible or monitoring HBV viral load more closely.

Also, do not use Lamivir HBV together with other medicines containing lamivudine or emtricitabine unless a healthcare professional specifically instructs you to do so.

Lamivudine 100mg Price

The price of Lamivir HBV 100mg varies according to country, pharmacy, pack size, taxes, supplier, and availability.

Online prices can change over time. Therefore, check the current price and availability before ordering.

Price should not be the only factor when choosing prescription medicine. Product authenticity, appropriate storage, legal dispensing, and professional medical supervision are also important.

How Should Lamivir HBV 100mg Be Stored?

Store Lamivir HBV according to the instructions printed on the packaging.

• Keep the tablets in their original packaging.
• Protect the medicine from excessive moisture.
• Store it according to the temperature instructions on the label.
• Keep all medicines away from children and pets.
• Do not use tablets if the packaging is damaged or the product looks unusual.

Lamivir HBV 100mg Frequently Asked Questions

What is Lamivir HBV 100mg?

Lamivir HBV 100mg is a prescription tablet containing lamivudine 100mg. It is used for chronic hepatitis B in appropriate patients.

What is Lamivudine 100mg used for?

Lamivudine 100mg is used to treat chronic hepatitis B associated with evidence of viral replication and active liver inflammation.

What is the usual lamivudine 100mg dose for hepatitis B?

The current U.S. HBV label recommends 100mg once daily for adults. Kidney impairment may require dosage adjustment.

What is 3TC?

3TC is another name for lamivudine. The terms refer to the same active ingredient.

Is Lamivir HBV 100mg an HIV medicine?

No. The 100mg HBV formulation is intended for chronic hepatitis B. Higher-dose lamivudine formulations are used as part of HIV treatment.

Can Lamivir HBV 100mg treat HIV?

No. The HBV formulation provides a lower lamivudine dose and is not appropriate as HIV treatment. People with HIV require an appropriate combination antiretroviral regimen.

Can I take Lamivir HBV with emtricitabine?

The current HBV label states that lamivudine HBV tablets should not be used with medicines containing emtricitabine. Follow your healthcare professional’s medication plan.

Can I take Lamivir HBV with food?

Lamivudine can generally be taken with or without food.

Can I stop Lamivir HBV when I feel better?

No. Do not stop treatment without medical advice because hepatitis B can worsen after discontinuation.

Does Lamivir HBV cure hepatitis B?

No. Lamivudine suppresses HBV replication but does not guarantee a cure for chronic hepatitis B.

What are the main lamivudine side effects?

Reported reactions with the HBV formulation include diarrhea, sore throat, and ear, nose, and throat infections. Other reactions can occur.

U.S. Medical Information for Lamivir HBV 100mg Lamivudine

For additional information about lamivudine and chronic hepatitis B, use authoritative medical sources.

• DailyMed – Lamivudine Tablets (HBV)
  
• MedlinePlus – Lamivudine Drug Information
  
• FDA – EPIVIR-HBV Prescribing Information
  
• U.S. Food and Drug Administration – Drugs
  
• NIH Clinical Guidelines
  

These resources provide additional information about indications, dosing, warnings, resistance, interactions, and treatment considerations.

Explore More Medicines

Visit our online medicine collection to explore other available products.

You can also visit our medicine homepage for additional product information and healthcare resources.

Regulatory Information

Lamivudine is an established prescription antiviral ingredient. However, the regulatory status, strength, formulation, brand name, and approved indication can vary between countries.

Lamivir HBV is a specific Cipla brand and should not automatically be described as FDA-approved simply because lamivudine has approved U.S. products.

The current U.S. HBV labeling identifies 100mg lamivudine tablets for chronic hepatitis B. The same active ingredient appears in different strengths and formulations for HIV treatment, so product-specific labeling matters.

Important Medical Disclaimer

This page provides general educational information about Lamivir HBV 100mg and lamivudine. It does not replace diagnosis, prescription, or advice from a qualified healthcare professional.

Lamivir HBV 100mg is a prescription medicine. Do not start, stop, or change the dose without professional medical advice.

Patients receiving treatment for chronic hepatitis B should receive appropriate clinical and laboratory monitoring. HIV testing may also be important before and during treatment with the HBV-specific lamivudine formulation.

Availability, prescribing, dispensing, importation, and use of prescription medicines may be subject to local laws and regulations. Verify legal eligibility and product requirements before ordering.

Always consult a licensed healthcare professional before using Lamivir HBV 100mg.